Found 435 matching trials
MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies PHASE2 In this study, treosulfan is evaluated for conditioning in allogenic stem c...
Show More Location
Hôpital Edouard Herriot
Learn More & Join Trial
PRO#0118: Decitabine Plus Mini Flu-Bu PHASE1 This is a single institution study of combining decitabine with fludarabine...
Show More Location
Hackensack University Medical Center - John Theurer Cancer Center
Learn More & Join Trial
A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML) PHASE1 This open-label Phase I study is designed to determine the maximum tolerate...
Show More Location
Weill Cornell Medical College
Learn More & Join Trial
Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant PHASE2 The purpose of this study is to compare Reduced Intensity Conditioning prot...
Show More Location
Ematologia e Centro Trapianti Midollo Osseo - Ospedale IRCCS Casa Sollievo della Sofferenza
Learn More & Join Trial
AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis PHASE1 One of the possible options for the treatment of MS at present is a high-do...
Show More Location
First Pavlov State Medical University of St. Petersburg
Learn More & Join Trial
Allo HSCT Using RIC for Hematological Diseases PHASE2 This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
AEROBIC ADAPTATION AND BIOMARKER RESPONSES IN COMBAT ATHLETES NA This randomized controlled study investigates the effects of sport-specific...
Show More Location
Adiyaman University Faculty of Sport Sciences
Learn More & Join Trial
Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers PHASE2 Giving chemotherapy drugs, such as fludarabine and busulfan, before a donor...
Show More Location
University of California Davis Cancer Center
Learn More & Join Trial
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor PHASE2 This is a Phase II, open-label, two strata, multicenter, prospective study ...
Show More Location
H. Lee Moffitt Cancer Center
Learn More & Join Trial
Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma PHASE1 Neuroblastoma is a malignant tumor of the sympathetic nervous system. It is...
Show More Location
Columbia Presbyterian Medical Center, Morgan Stanley Children's Hospital New York Presbyterian
Learn More & Join Trial